Kasumi-1细胞系

KASUMI-1/KASUMI-1细胞系/KASUMI-1细胞株/KASUMI-1人红白血病细胞

Cell line name Kasumi-1

Synonyms KASUMI-1; Kasumi 1; KASUMI1; Kasumi1

Accession CVCL_0589

Resource Identification Initiative To cite this cell line use: Kasumi-1 (RRID:CVCL_0589)

Comments Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).

Part of: COSMIC cell lines project.

Part of: LL-100 blood cancer cell line panel.

Part of: MD Anderson Cell Lines Project.

Part of: NCI Pediatric Preclinical Testing Program (PPTP) cell line panel.

Population: Japanese.

Doubling time: 40-45 hours (PubMed=2018839); 40 hours (PubMed=25984343); 53 hours (PubMed=20922763); ~48-72 hours (DSMZ=ACC-220).

Karyotypic information: Has lost chromosome Y (PubMed=2018839).

Karyotypic information: Some chromosome Y fragments are integrated into other chromosomes (PubMed=18292219).

Microsatellite instability: Stable (MSS) (PubMed=10739008; PubMed=11226526; Sanger).

Omics: Array-based CGH.

Omics: Deep exome analysis.

Omics: Deep quantitative proteome analysis.

Omics: DNA methylation analysis.

Omics: Genome sequenced.

Omics: miRNA expression profiling.

Omics: Protein expression by reverse-phase protein arrays.

Omics: shRNA library screening.

Omics: SNP array analysis.

Omics: Transcriptome analysis by microarray.

Omics: Transcriptome analysis by RNAseq.

Misspelling: Kusami-1; Cosmic=1516633; Cosmic=1623636; Cosmic=2750859.

Misspelling: KUSAMI-1; Cosmic=2306211.

Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.

PubMed=9738977; DOI=10.1111/j.1349-7006.1998.tb03275.x; PMCID=PMC5921886

Takizawa J., Suzuki R., Kuroda H., Utsunomiya A., Kagami Y., Joh T., Aizawa Y., Ueda R., Seto M.

Expression of the TCL1 gene at 14q32 in B-cell malignancies but not in adult T-cell leukemia.

Jpn. J. Cancer Res. 89:712-718(1998)

 

PubMed=10739008; DOI=10.1016/S0145-2126(99)00182-4

Inoue K., Kohno T., Takakura S., Hayashi Y., Mizoguchi H., Yokota J.

Frequent microsatellite instability and BAX mutations in T cell acute lymphoblastic leukemia cell lines.

Leuk. Res. 24:255-262(2000)

 

DOI=10.1016/B978-0-12-221970-2.50457-5

Drexler H.G.

The leukemia-lymphoma cell line factsbook.

(In book) ISBN 9780122219702; pp.1-733; Academic Press; London; United Kingdom (2001)

 

PubMed=11226526; DOI=10.1016/S0145-2126(00)00121-1

Inoue K., Kohno T., Takakura S., Hayashi Y., Mizoguchi H., Yokota J.

Corrigendum to: Frequent microsatellite instability and BAX mutations in T cell acute lymphoblastic leukemia cell lines Leukemia Research 24 (2000), 255-262.

Leuk. Res. 25:275-278(2001)

 

PubMed=11753612; DOI=10.1038/sj.leu.2402318

Xiao Z.-X., Greaves M.F., Buffler P.A., Smith M.T., Segal M.R., Dicks B.M., Wiencke J.K., Wiemels J.L.

Molecular characterization of genomic AML1-ETO fusions in childhood leukemia.

Leukemia 15:1906-1913(2001)

 

PubMed=12111653; DOI=10.1038/sj.thj.6200168

Beghini A., Magnani I., Ripamonti C.B., Larizza L.

Amplification of a novel c-Kit activating mutation Asn(822)-Lys in the Kasumi-1 cell line: a t(8;21)-Kit mutant model for acute myeloid leukemia.

Hematol. J. 3:157-163(2002)

 

PubMed=15621809; DOI=10.1080/10428190400007565

Larizza L., Magnani I., Beghini A.

The Kasumi-1 cell line: a t(8;21)-kit mutant model for acute myeloid leukemia.

Leuk. Lymphoma 46:247-255(2005)

 

PubMed=15843827; DOI=10.1038/sj.leu.2403749

Andersson A., Eden P., Lindgren D., Nilsson J., Lassen C., Heldrup J., Fontes M., Borg A., Mitelman F., Johansson B., Hoglund M., Fioretos T.

Gene expression profiling of leukemic cell lines reveals conserved molecular signatures among subtypes with specific genetic aberrations.

Leukemia 19:1042-1050(2005)

 

PubMed=16408098; DOI=10.1038/sj.leu.2404081

Quentmeier H., MacLeod R.A.F., Zaborski M., Drexler H.G.

JAK2 V617F tyrosine kinase mutation in cell lines derived from myeloproliferative disorders.

Leukemia 20:471-476(2006)

 

PubMed=16523483; DOI=10.1002/gcc.20317

Horsley S.W., Mackay A., Iravani M., Fenwick K., Valgeirsson H., Dexter T.J., Ashworth A., Kearney L.

Array CGH of fusion gene-positive leukemia-derived cell lines reveals cryptic regions of genomic gain and loss.

Genes Chromosomes Cancer 45:554-564(2006)

 

PubMed=18292219; DOI=10.1101/gr.068304.107; PMCID=PMC2336809

Chen J., Kim Y.C., Jung Y.-C., Xuan Z.-Y., Dworkin G., Zhang Y.-M., Zhang M.Q., Wang S.M.

Scanning the human genome at kilobase resolution.

Genome Res. 18:751-762(2008)

 

PubMed=18385756; DOI=10.1038/leu.2008.61

Becker H., Pfeifer D., Duque-Afonso J., Nimer S.D., Veelken H., Schwabe M., Lubbert M.

Two cell lines of t(8;21) acute myeloid leukemia with activating KIT exon 17 mutation: models for the 'second hit' hypothesis.

Leukemia 22:1792-1794(2008)